EPIDEMIOLOGIA DE LA BACTERIEMIA POR KLEBSIELLA AEROGENES EN PACIENTES CON COVID-19
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Rev. Méd. La Paz
Abstract
El objetivo de este estudio es determinar la prevalencia de la bacteriemia por Klebsiella aerogenes en pacientes adultos con COVID-19 internados en la Unidad de Terapia Intensiva del Hospital San Juan de Dios de la ciudad de Oruro, durante los años 2021 y 2022. Material y método: Se llevó a cabo un estudio cuantitativo de tipo retrospectivo, observacional, transversal de prevalencia. El método análisis se basó en la revisión documental, los instrumentos fueron los expedientes clínicos y el certificado médico único de defunción (CEMEUD). Resultados: La prevalencia de Bacteriemia por K. aerogenes en 253 pacientes adultos mayores de 18 años con COVID-19 en la Unidad de Terapia Intensiva fue del 12.65%; del total de 32 pacientes con bacteriemia K. aerogenes y COVID-19 el promedio de la edad fue de 60.06 años IC95% (55.48-64.65); el tiempo de internación 15.66 días IC95% (11.95-19.36); respecto a las Enfermedades Crónicas no Transmisibles la proporción de la Diabetes Mellitus tipo 2 fue 9.5% (24), Insuficiencia Renal Aguda 6.3% (16), Hipertensión Arterial Sistémica 5.9% (15), y Obesidad 3.6% (9); por último la proporción de cándida albicans 15.6% (5), Staphylococcus coagulasa negativo 6.3% (2), otros patógenos 3.1% (1). Conclusión: Se encontró que la prevalencia de Bacteriemia causada por K. aerogenes en adultos mayores de 18 años con COVID-19 fue del 12.65%.
The objective of this study is to determine the prevalence of Klebsiella aerogenes bacteriemia in adult patients with COVID-19 admitted to the Intensive Care Unit of the San Juan de Dios Hospital in the city of Oruro, during the years 2021 and 2022. Material and method: A retrospective, observational, cross-sectional quantitative prevalence study was carried out. The analysis method was based on documentary review, the Instruments were the clinical records and the single medical death certifícate (CEMEUD). Results: The prevalence of K. aerogenes bacteriemia in 253 adult patients over 18 years of age with COVID-19 in the Intensive Care Unit was 12.65%; of the total of 32 patients with K. aerogenes bacteriemia and COVID-19, the average age was 60.06 years CI95% (55.48-64.65); the length of hospital stay was 15.66 days 95% CI (11.95-19.36); regarding Non-Communicable Chronic Diseases, the proportion of type 2 Diabetes Mellitus was 9.5% (24), Acute Renal Failure 6.3% (16), Systemic Arterial Hypertension 5.9% (15), and Obesity 3.6% (9); finally, the proportion of Candida albicans was 15.6% (5), Coagulase-negative Staphylococcus 6.3% (2), and other pathogens 3.1% (1). Conclusión: The prevalence of Bacteriemia caused by K. aerogenes in adults over 18 years of age with COVID-19 was 12.65%.
The objective of this study is to determine the prevalence of Klebsiella aerogenes bacteriemia in adult patients with COVID-19 admitted to the Intensive Care Unit of the San Juan de Dios Hospital in the city of Oruro, during the years 2021 and 2022. Material and method: A retrospective, observational, cross-sectional quantitative prevalence study was carried out. The analysis method was based on documentary review, the Instruments were the clinical records and the single medical death certifícate (CEMEUD). Results: The prevalence of K. aerogenes bacteriemia in 253 adult patients over 18 years of age with COVID-19 in the Intensive Care Unit was 12.65%; of the total of 32 patients with K. aerogenes bacteriemia and COVID-19, the average age was 60.06 years CI95% (55.48-64.65); the length of hospital stay was 15.66 days 95% CI (11.95-19.36); regarding Non-Communicable Chronic Diseases, the proportion of type 2 Diabetes Mellitus was 9.5% (24), Acute Renal Failure 6.3% (16), Systemic Arterial Hypertension 5.9% (15), and Obesity 3.6% (9); finally, the proportion of Candida albicans was 15.6% (5), Coagulase-negative Staphylococcus 6.3% (2), and other pathogens 3.1% (1). Conclusión: The prevalence of Bacteriemia caused by K. aerogenes in adults over 18 years of age with COVID-19 was 12.65%.
Description
Vol. 30, No. 3